Patents by Inventor Ángel Rumbero Sánchez
Ángel Rumbero Sánchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11981878Abstract: The present invention relates to a method for municipal solid waste (MSW) reclamation in a continuous or discontinuous process first for converting said waste into organic biomass and subsequently extracting and recovering the most chemical compounds contained in said biomass possible, such as triglycerides, sugars and proteins. Therefore, the invention is comprised in the field of recycling, transforming solid waste into reusable solids and biofuels.Type: GrantFiled: June 21, 2019Date of Patent: May 14, 2024Assignee: ECONWARD TECH.Inventors: Rubén García Cano, Jorge Crespo Lobo, Ángel Rumbero Sanchez, Nuria Cano Adamuz, Alejandro Villacampa Sanagustín, Oscar Orozco González
-
Publication number: 20230348365Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.Type: ApplicationFiled: January 18, 2023Publication date: November 2, 2023Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
-
Patent number: 11584710Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.Type: GrantFiled: July 31, 2018Date of Patent: February 21, 2023Assignee: HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁGInventors: Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
-
Publication number: 20220364017Abstract: The present invention relates to a method for municipal solid waste (MSW) reclamation in a continuous or discontinuous process first for converting said waste into organic biomass and subsequently extracting and recovering the most chemical compounds contained in said biomass possible, such as triglycerides, sugars and proteins. Therefore, the invention is comprised in the field of recycling, transforming solid waste into reusable solids and biofuels.Type: ApplicationFiled: June 21, 2019Publication date: November 17, 2022Inventors: Rubén GARCÍA CANO, Jorge CRESPO LOBO, Ángel RUMBERO SANCHEZ, Nuria CANO ALAMUZ, Alejandro VILLACAMPA SANAGUSTÍN, Oscar OROZCO GONZÁLEZ
-
Publication number: 20220315544Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer or solvate thereof for use in the prevention and/or treatment of a pathology associated with proinflammatory conditions, a disease associated with oxidative stress or production of reactive oxygen species or a skin pigmentation disorder. In addition, the invention also relates to a cosmetic method for preventing and/or treating skin aging, irradiated skin or for skin-whitening comprising administering a compound of formula (I) or a cosmetically acceptable salt, stereoisomer or solvate thereof. In addition, the invention relates to a method of inhibition of enzymatic browning in food or beverage comprising contacting said food or beverage with a compound of formula (I) or a salt, stereoisomer or solvate thereof under conditions sufficient to inhibit enzymatic browning of said food or beverage.Type: ApplicationFiled: June 1, 2020Publication date: October 6, 2022Inventors: ALFREDO HERNÁNDEZ CABANILLAS, SANTIAGO MADERUELO CORRAL, MONTSERRAT ORTEGA DOMÉNECH, DIEGO FERNANDO ROSERO VALENCIA, ÁNGEL RUMBERO SÁNCHEZ, VICTOR TENA PÉREZ, LUIS NÉSTOR APAZA TICONA
-
Patent number: 11241440Abstract: The invention relates to the use of 1-(4,6-dipentyl-5,6-dihydro-2H-1,2,3-oxadiazin-2-yl)-3-hydroxypropan-1-one in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compound of formula (I) of the invention, said process comprising the steps of cultivating a strain of Dolichospermum sp in an aqueous nutrient medium with assimilable carbon and nitrogen sources and salts, under controlled aerobic conditions, and then recovering the compound of general formula (I) from the culture broth.Type: GrantFiled: December 29, 2016Date of Patent: February 8, 2022Assignee: Valoralia | Mas D, SLInventors: Ana María González Fuente, Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
-
Publication number: 20210155578Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.Type: ApplicationFiled: July 31, 2018Publication date: May 27, 2021Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
-
Patent number: 11008295Abstract: The invention relates to novel compounds and their use in medicine, particularly in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compounds of the invention.Type: GrantFiled: April 25, 2018Date of Patent: May 18, 2021Assignee: HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁGInventors: Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
-
Publication number: 20200316082Abstract: The invention relates to the use of 1-(4,6-dipentyl-5,6-dihydro-2H-1,2,3-oxadiazin-2-yl)-3-hydroxypropan-1-one in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compound of formula (I) of the invention, said process comprising the steps of cultivating a strain of Dolichospermum sp in an aqueous nutrient medium with assimilable carbon and nitrogen sources and salts, under controlled aerobic conditions, and then recovering the compound of general formula (I) from the culture broth.Type: ApplicationFiled: December 29, 2016Publication date: October 8, 2020Inventors: Ana María GONZÁLEZ FUENTE, Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
-
Publication number: 20200190044Abstract: The invention relates to novel compounds and their use in medicine, particularly in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compounds of the invention.Type: ApplicationFiled: April 25, 2018Publication date: June 18, 2020Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
-
Publication number: 20140309295Abstract: The present invention describes a compound of formula (I) its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for its use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with undesired oxidation, age-associated pathological processes and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, or fungal or viral infections.Type: ApplicationFiled: June 25, 2014Publication date: October 16, 2014Inventors: Javier Santos BURGOS MUÑOZ, José Luis ADRIO FONDEVILA, Maria del Carmen RAMOS MARTÍN, Saleta SIERRA ÁVILA, Juan Maria ALFARO SÁNCHEZ, Carlos RAMÍREZ MORENO, Sonia CAMPOY GARCIA, Javier VELASCO ALVAREZ, Ángel RUMBERO SÁNCHEZ
-
Publication number: 20120095091Abstract: The present invention describes a compound of formula (I) its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for its use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with undesired oxidation, age-associated pathological processes and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, or fungal or viral infections.Type: ApplicationFiled: April 16, 2010Publication date: April 19, 2012Applicant: Neuron Biopharma S.AInventors: Javier Santos Burgos Muñoz, José Luis Adrio Fondevila, Maria del Carmen Ramos Martín, Saleta Sierra Ávila, Juan María Alfaro Sánchez, Carlos Ramírez Moreno, Sonia Campoy García, Javier Velasco Alvarez, Ángel Rumbero Sánchez
-
Publication number: 20110319484Abstract: The invention describes the use of (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl-1-naphthalenyl propanoate derivatives, optionally mono- or di-methylated at the carbon in the alpha position of propanoic acid, of formula (I), where R is CH3CH2CO—, (CH3)2CHCO— or (CH3)3CCO—, its hydroxy acid forms and the pharmaceutically acceptable salts of said hydroxy acids, as neuroprotective compounds potentially useful for the prevention and/or treatment of neurodegenerative diseases, or of diseases associated with an unwanted oxidation or of age-associated pathological processes, or of epilepsy, epileptic seizures or convulsions.Type: ApplicationFiled: March 5, 2010Publication date: December 29, 2011Applicant: Parque Tecnologico de Ciencias de la SaludInventors: Javier Santos Burgos Muñoz, Maria del Carmen Ramos Martín, Saleta Sierra Ávila, Juan María Alfaro Sánchez, Javier Velasco Alvarez, Ángel Rumbero Sánchez, Carlos Ramírez Moreno